Applying the Latest Evidence in Targeting JAK2 in Myelofibrosis: Clinical Updates for the Specialty Pharmacist

May 3, 2021 | 8:00 pm ET
This activity is supported by an educational grant from Bristol Myers Squibb.

A Pharmacist Considerations for New and Emerging Oral Oncolytics: Optimizing Therapy and Care for Patients Receiving Treatment

May 4, 2021 | 1:00 pm ET

This activity is supported by educational grants from Blueprint Medicines and Epizyme Inc.

Closing the Gap in Hemophilia Care: Therapeutic Advances in Hemophilia A and B

May 4, 2021 | 8:00 pm ET

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Non-Hodgkin Lymphoma: A Focus on Targeted Solutions to Oral Therapy Nonadherence

May 5, 2021 | 1:00 pm ET

This activity is supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.

Effective Utilization of Combination Therapies in Pulmonary Arterial Hypertension (PAH): Working Towards Low Risk Status for Patients, featuring Evidence-Based Case Reviews

May 5, 2021 | 8:00 pm ET

This activity is supported by educational grants from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson

Addressing Unmet Needs in the Management of Idiopathic Pulmonary Fibrosis: The Role of Specialty Pharmacists

May 6, 2021 | 1:00 pm ET

This activity is supported by educational grants from Boehringer Ingelheim and Genentech, a member of the Roche Group

Slowing the Spread of the Influenza Virus and Managing Symptoms: Considerations for Managed Care Professionals

May 6, 2021 | 8:00 pm ET

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

The Role of Interleukin Pathways in Reducing the Clinical and Economic Burden of Psoriatic Disease: Updates for Specialty Pharmacists

May 7, 2021 | 1:00 pm ET

This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Managing Multiple Sclerosis: Examining Oral Treatment Options and Specialty Pharmacy Considerations

May 10, 2021 | 8:00 pm ET

This activity is supported by educational grants from EMD Serono and Bristol Myers Squibb.

Effectively Managing Moderate to Severe Pediatric Atopic Dermatitis: Applying Evidence-Based Case Reviews in Practice

May 11, 2021 | 8:00 pm ET

This activity is supported by an educational grant from GlaxoSmithKline.

Advancements in Treating and Managing Long-Chain Fatty Acid Oxidation Disorders, featuring a Patient Perspective

May 12, 2021 | 1:00 pm ET

This activity is supported by an educational grant from Ultragenyx Pharmaceutical Inc.

Highlighting Novel and Emerging Monoclonal Antibody Therapy for Neovascular Age Related Macular Degeneration and Diabetic Macular Edema

May 12, 2021 | 8:00 pm ET

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Improving Visual Acuity and Patient Adherence in Neovascular Age-Related Macular Degeneration: A Review of Novel and Emerging Therapies for Specialty Pharmacists

May 13, 2021 | 8:00 pm ET

This activity is supported by educational grants from Genentech, a member of the Roche Group, and Regeneron.

The Evolving Treatment Landscape for Neuromyelitis Optica Spectrum Disorder: Updates for Specialty and Infusion Pharmacists

May 17, 2021 | 8:00 pm ET

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Treatment Advances in Atopic Dermatitis Care: Updates for the Specialty Pharmacist

May 27, 2021 | 8:00 pm ET

This activity is supported by an educational grant from Incyte Corporation.